Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis

Tsz-Fung F Chow1, Youssef M Youssef, Evi Lianidou

  • 1Department of Laboratory Medicine, and the Keenan Research Centre in the Li Ka Shing Knowledge Institute St Michael's Hospital, Toronto, Canada.

Clinical Biochemistry
|August 4, 2009
PubMed
Abstract

Insights

Researchers identified 33 microRNAs (miRNAs) dysregulated in clear cell renal cell carcinoma (ccRCC). These findings suggest potential roles in kidney cancer pathogenesis and utility as diagnostic biomarkers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Kidney cancer, specifically clear cell renal cell carcinoma (ccRCC), is a significant health concern.
  • MicroRNAs (miRNAs) play crucial roles in cellular processes and are implicated in various cancers.

Purpose of the Study:

  • To identify differentially expressed miRNAs in ccRCC tissues compared to normal kidney tissues.
  • To explore the potential role of these miRNAs in ccRCC pathogenesis and as diagnostic biomarkers.

Main Methods:

  • Microarray analysis was employed to screen for differentially expressed miRNAs between ccRCC and normal tissues.
  • Quantitative RT-PCR was used to validate the expression levels of key dysregulated miRNAs.
  • Bioinformatics analyses, including target prediction, were performed to understand miRNA function.

Main Results:

  • A total of 33 dysregulated miRNAs were identified in ccRCC, with 21 showing upregulation.
  • Many identified miRNAs have known associations with other malignancies and cancer development.
  • Correlations were found between miRNA expression and chromosomal aberration sites, suggesting genetic involvement.
  • Predicted gene targets of these miRNAs appear to be directly involved in renal cell carcinoma pathogenesis.

Conclusions:

  • This study successfully identified a set of miRNAs dysregulated in ccRCC.
  • Bioinformatics analysis supports the involvement of these miRNAs in kidney cancer development.
  • The identified miRNAs hold promise as potential biomarkers for ccRCC diagnosis and prognosis.